Koshigaya, Japan

Yutaka Kokie

This inventor holds 1 USPTO granted patent. Top assignee: Banyu Pharmaceutical Co. Ltd. Active years: 1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yutaka Kokie. Retrieved from https://idiyas.com/inventor/yutaka-kokie

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 1995

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yutaka Kokie: Innovator in Acylamino Acid Compounds

Introduction

Yutaka Kokie is a notable inventor based in Koshigaya, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on acylamino acid compounds. His expertise and dedication have led to the development of valuable patents that enhance the pharmaceutical industry.

Latest Patents

Yutaka Kokie holds a patent for N-substituted acylamino acid compounds. This patent outlines a process for their production and highlights the pharmaceutical uses of these compounds. The invention provides an N-substituted acylamino acid compound of a specific formula, along with intermediates useful for their production.

Career Highlights

Kokie is associated with Banyu Pharmaceutical Co. Ltd., where he has been instrumental in advancing research and development in pharmaceutical applications. His work has not only contributed to the company's portfolio but has also impacted the broader field of medicinal chemistry.

Collaborations

Throughout his career, Yutaka Kokie has collaborated with esteemed colleagues such as Hajime Morishima and Masato Nakano. These collaborations have fostered a productive environment for innovation and have led to the successful development of new pharmaceutical compounds.

Conclusion

Yutaka Kokie's contributions to the field of acylamino acid compounds exemplify the importance of innovation in pharmaceuticals. His work continues to influence the industry and pave the way for future advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…